Identification of a Novel CD8 T Cell Epitope Derived from Plasmodium berghei Protective Liver-Stage Antigen.

about

Identification of a Novel CD8 T Cell Epitope Derived from Plasmodium berghei Protective Liver-Stage Antigen.

Item

http://www.wikidata.org/entity/Q50054503

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Identification of a Novel CD8 ...... rotective Liver-Stage Antigen.

@en

Identification of a Novel CD8 ...... rotective Liver-Stage Antigen.

@nl

type

Item

label

Identification of a Novel CD8 ...... rotective Liver-Stage Antigen.

@en

Identification of a Novel CD8 ...... rotective Liver-Stage Antigen.

@nl

prefLabel

Identification of a Novel CD8 ...... rotective Liver-Stage Antigen.

@en

Identification of a Novel CD8 ...... rotective Liver-Stage Antigen.

@nl

P1476

Identification of a Novel CD8 ...... rotective Liver-Stage Antigen.

@en

P2093

Alexander Pichugin

http://www.w3.org/2001/XMLSchema#string

Hidde Lolke Ploegh

http://www.w3.org/2001/XMLSchema#string

Leah Perazzo

http://www.w3.org/2001/XMLSchema#string

Patrick Emmet Duffy

http://www.w3.org/2001/XMLSchema#string

Stasya Zarling

http://www.w3.org/2001/XMLSchema#string

Urszula Krzych

http://www.w3.org/2001/XMLSchema#string

P2860

Genome sequence of the human malaria parasite Plasmodium falciparum

In vivo CD8+ T cell dynamics in the liver of Plasmodium yoelii immunized and infected mice

Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging

Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers

Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein

Plasmodium cellular effector mechanisms and the hepatic microenvironment

ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites

Phagosomes are competent organelles for antigen cross-presentation

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.00091

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29434602

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium berghei

P932

5796907

http://www.w3.org/2001/XMLSchema#string